Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tax exemption and integrated delivery systems

W J Aseltyne1, G R Peters

  • 1California Pacific Medical Center, San Francisco.

Topics in Health Care Financing
|January 1, 1994
PubMed
Summary

This chapter explains tax exemption for integrated delivery systems, covering charitable purpose, private inurement, and private benefit tests. It analyzes nonprofit medical foundations and the process for obtaining tax exemption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Journal of clinical pharmacology·2014
Same author

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.

Journal of clinical pharmacology·1999
Same author

Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation.

The Journal of pharmacology and experimental therapeutics·1998
Same author

Induction of tirilazad clearance by phenytoin.

Biopharmaceutics & drug disposition·1998
Same author

Steady-state pharmacokinetic properties of pramipexole in healthy volunteers.

Journal of clinical pharmacology·1997

Area of Science:

  • Healthcare Law
  • Tax Law
  • Nonprofit Management

Background:

  • Integrated delivery systems (IDS) are complex healthcare organizations.
  • Understanding tax-exempt status is crucial for nonprofit healthcare providers.
  • The Internal Revenue Service (IRS) scrutinizes the structure and operations of healthcare organizations seeking tax exemption.

Purpose of the Study:

  • To elucidate the requirements for tax exemption for integrated delivery systems.
  • To analyze the application of charitable purpose, private inurement, and private benefit tests to IDS.
  • To examine the IRS's analysis of specific nonprofit medical foundations.

Main Methods:

  • Review of relevant tax law and IRS regulations.
  • Case study analysis of Friendly Hills and Facey Nonprofit Medical Foundations.
  • Discussion of legal precedents and IRS rulings concerning healthcare tax exemption.

Main Results:

  • Tax exemption for IDS hinges on meeting stringent requirements, including the charitable purposes test.
  • The private inurement and private benefit tests are critical in assessing an IDS's eligibility.
  • IRS analysis of foundations like Friendly Hills and Facey provides insights into exemption criteria.

Conclusions:

  • Successfully obtaining tax exemption requires a thorough understanding of legal tests and IRS expectations.
  • The structure and operations of IDS must align with nonprofit principles to maintain tax-exempt status.
  • Navigating the process for tax exemption involves careful documentation and adherence to regulatory guidelines.

Related Experiment Videos